Anaptysbio (ANAB) Accumulated Expenses: 2016-2025
Historic Accumulated Expenses for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $33.2 million.
- Anaptysbio's Accumulated Expenses fell 13.62% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year decrease of 13.62%. This contributed to the annual value of $39.5 million for FY2024, which is 27.56% up from last year.
- According to the latest figures from Q3 2025, Anaptysbio's Accumulated Expenses is $33.2 million, which was up 9.85% from $30.2 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Accumulated Expenses ranged from a high of $39.5 million in Q4 2024 and a low of $11.8 million during Q1 2021.
- Over the past 3 years, Anaptysbio's median Accumulated Expenses value was $33.2 million (recorded in 2025), while the average stood at $33.2 million.
- As far as peak fluctuations go, Anaptysbio's Accumulated Expenses declined by 22.40% in 2021, and later skyrocketed by 110.39% in 2023.
- Anaptysbio's Accumulated Expenses (Quarterly) stood at $12.9 million in 2021, then skyrocketed by 68.31% to $21.6 million in 2022, then soared by 43.15% to $31.0 million in 2023, then grew by 27.56% to $39.5 million in 2024, then dropped by 13.62% to $33.2 million in 2025.
- Its Accumulated Expenses stands at $33.2 million for Q3 2025, versus $30.2 million for Q2 2025 and $36.0 million for Q1 2025.